Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02137772
Brief Title: Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

First Submitted : May 12, 2014
First Submitted that Met QC Criteria : May 12, 2014
First Posted : May 14, 2014 (Estimate)

Results First Submitted : October 16, 2017
Results First Submitted that Met QC Criteria : October 16, 2017
Results First Posted : November 17, 2017

Last Update Submitted that Met QC Criteria : September 27, 2018
Last Update Posted : October 25, 2018